Four dominant e-cigarette manufacturers face an examination into the health impacts of their products because the U.S. House Energy and Commerce Committee requested on Wednesday in regards to the corporations’ analysis and advertising and marketing practices.
The board sent letters to Juul Labs Inc, 35% owned by Marlboro producer Altria Group Inc, Fontem Ventures, Japan Tobacco Inc, also Reynolds American Inc, a unit of British American Tobacco Plc.
The letter to Juul demanded if the company has conducted or supported research on the health associations of using its products and the effectiveness of Juul in helping users quit smoking. It asked if Juul has sent info to the Food and Drug Administration.
Kaelan Hollon, the spokeswoman for Reynolds American, said the company is reviewing the letter and believes, they noted: minors should never use tobacco merchandise, together with vapor products.
Japan Tobacco said in the announcement it welcomes any alternative to “set out the accountable approaches” it demands in its marketing.
Juul and Fontem Ventures didn’t respond to requests for comment.
The examination comes amid growing scrutiny of the e-cigarette business by lawmakers. A separate House panel in July launched internal Juul emails that committee employees described as attempts to “enter schools and convey it is messaging on to teenagers.”
James Monsees, Juul’s co-founder and chief stock officer, advised the panel the company’s audience is adult cigarette people who smoke.
Representative Frank Pallone, he is Democratic chairman of the committee, told vaping-associated lung sicknesses not too long ago reported by the Centers for Disease Control and Prevention. He requested answers and documents by Sept. 20.
The CDC said on Wednesday it is investigating 153 possible instances of severe lung illness related to e-cigarette use in 16 states. No deaths have been reported, they said.